KRONOS® AIR DISINFECTION TECHNOLOGY MANUFACTURER RECEIVES FDA 510(K) CLASS II MEDICAL DEVICE CLEARANCE FOR THE DESTRUCTION OF VIRUSES, BACTERIA, AND ALLERGENS.
Parkersburg, WV, Jan. 10, 2023 (GLOBE NEWSWIRE) — Parkersburg, WV January 10, 2023 /Globenewswire/ KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), innovation-driven product development and creator of patented Kronos® CORE air disinfection technology inside its advanced smart air purification devices, announced today that the U.S. Food and Drug Administration (FDA) has recently granted 510(k) clearance, classifying it as a Class II Medical Device. The FDA clearance was provided to the product manufacturer after a detailed review of the patented Model 5 device, which utilizes patented High Voltage Field air disinfection technology and is proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses, like COVID-19. FDA Clearance which means our air purifiers can be deployed in hospitals and home health-care settings to clear the air of infected bioaerosol droplets , in addition, our products comply with all CARB regulations related to air cleaners for sale in California, and the Company’s manufacturer is registered with the State of California CARB.
Related news for (KNOS)
- KRONOS ADVANCED TECHNOLOGIES FDA-CLEARED AIR PURIFIERS PROVIDE RELIEF FROM CANADIAN WILDFIRE SMOKE
- KronosMD Inc Announces Filing Patent Application for Revolutionary Teeth Whitening Method Utilizing Company’s Patented Dental Ultrasound Technology.
- ChatGPT Integrated into Kronos’ Online e-Commerce Site Powered by Shopify
- KronosMD Inc’s CEO Files Provisional Patent Application for an Advanced Ultrasound Dental Digital Impression System
- KronosMD Inc., A Subsidiary Of $KNOS, is Set To Disrupt The Multi-Billion-Dollar Medical Ultrasound Imaging Industry Via Acquisition Of a Manufacturing-Ready Patent Portfolio.